DIRECTIONS FOR USE OF TAZICEF (CEFTAZIDIME FOR INJECTION, USP)
ADD-VANTAGE VIALS:
1g, 2g
To Open Diluent Container:
Peel the corner of the ADD-Vantage diluent overwrap and remove flexible diluent container. Some opacity of the plastic due to moisture absorption during the sterilization process may be observed. This is normal and does not affect the solution quality or safety. The opacity will diminish gradually.
To Assemble Vial and Flexible Diluent Container (Use Aseptic Technique):
To Prepare Admixture:
Preparation for Administration (Use Aseptic Technique):
WARNING: Do not use flexible container in series connections.
Manufactured by Sandoz GmbH for
Hospira, Inc., Lake Forest, IL 60045, USA
LAB-1447-1.0
Revised: 12/2020
DIRECTIONS FOR USE OF TAZICEF (CEFTAZIDIME FOR INJECTION, USP)
ADD-VANTAGE VIALS:
1g, 2g
To Open Diluent Container:
Peel the corner of the ADD-Vantage diluent overwrap and remove flexible diluent container. Some opacity of the plastic due to moisture absorption during the sterilization process may be observed. This is normal and does not affect the solution quality or safety. The opacity will diminish gradually.
To Assemble Vial and Flexible Diluent Container (Use Aseptic Technique):
To Prepare Admixture:
Preparation for Administration (Use Aseptic Technique):
WARNING: Do not use flexible container in series connections.
Manufactured by Sandoz GmbH for
Hospira, Inc., Lake Forest, IL 60045, USA
LAB-1447-1.0
Revised: 12/2020
{{section_body_html_patient}}
Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine.
*Speak with a Pfizer Medical Information Professional regarding your medical inquiry. Available 9AM-5PM ET Monday to Friday; excluding holidays.
Submit a medical question for Pfizer prescription products.
Pfizer Safety
To report an adverse event related to the Pfizer-BioNTech COVID-19 Vaccine, and you are not part of a clinical trial* for this product, click the link below to submit your information:
Pfizer Safety Reporting Site*If you are involved in a clinical trial for this product, adverse events should be reported to your coordinating study site.
If you cannot use the above website, or would like to report an adverse event related to a different Pfizer product, please call Pfizer Safety at (800) 438-1985.
FDA Medwatch
You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at www.fda.gov/medwatch or call (800) 822-7967.